Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ: SDGR )

22.11 -0.66 (-2.92%)
Streaming Delayed Price Updated: 10:58 AM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
My Favorite Biotech Stock Right Now
I'm an owner of Schrodinger because this company's software is revolutionizing drug discovery, and it's going to be a monster stock over the next decade. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
4 Penny Stocks With the Potential to Become Top-Notch AI Players
These four penny stocks could get a huge boost from the success of the underlying companies' AI systems going forward. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Schrodinger Insights: Return On Capital Employed
In Q1, Schrodinger (NASDAQ:SDGR) posted sales of $32.13 million. Earnings were up 44.19%, but Schrodinger still reported an overall loss of $23.91 million. In Q4, Schrodinger... 
Via Benzinga
Recap: Schrodinger Q1 Earnings
Shares of Schrodinger (NASDAQ:SDGR) decreased 1.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 100.00% over... 
Via Benzinga
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
Schrödinger to Present at Two Investor Healthcare Conferences in June
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrodinger Inc (SDGR) Q1 2021 Earnings Call Transcript
SDGR earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Looking Into Schrodinger's Return On Capital Employed
During Q1, Schrodinger's (NASDAQ:SDGR) reported sales totaled $32.13 million. Despite a 44.19% in earnings, the company posted a loss of $23.91 million. In Q4, Schrodinger brought... 
Via Benzinga
Schrödinger Reports First Quarter 2021 Financial Results and Provides Company Update
From Schrödinger, Inc.
Via Business Wire
Top 10 Stocks Owned By The Bill And Melinda Gates Foundation
The question on everyone’s minds is: What will happen to the Bill and Melinda Gates Foundation? The Foundation has invested in 18 stocks in total. We take a look at the top 10 stocks that make up its... 
Via Talk Markets
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple... 
Via Benzinga
Schrödinger to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
From Schrödinger
Via Business Wire
Schrödinger to Host Conference Call to Discuss First Quarter 2021 Financial Results
From Schrödinger
Via Business Wire
Upstart Holdings Has What It Takes to Be a Top AI Company
Upstart's AI platform, which is tailored to the lucrative financial sector, makes UPST stock very appealing. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrödinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting
From Schrödinger
Via Business Wire
Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery
From Schrödinger
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.